• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境与细胞融合。

Tumor Microenvironment and Cell Fusion.

机构信息

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, China.

Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

Biomed Res Int. 2019 Jul 11;2019:5013592. doi: 10.1155/2019/5013592. eCollection 2019.

DOI:10.1155/2019/5013592
PMID:31380426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6657644/
Abstract

Cell fusion is a highly regulated biological process that occurs under both physiological and pathological conditions. The cellular and extracellular environment is critical for the induction of the cell-cell fusion. Aberrant cell fusion is initiated during tumor progression. Tumor microenvironment is a complex dynamic system formed by the interaction between tumor cells and their surrounding cells. Cell-cell fusion mediates direct interaction between tumor cells and their surrounding cells and is associated with tumor initiation and progression. Various microenvironmental factors affect cell fusion in tumor microenvironment and generate hybrids that acquire genomes of both parental cells and exhibit novel characteristics, such as tumor stem cell-like properties, radioresistance, drug resistance, immune evasion, and enhanced migration and invasion abilities, which are closely related to the initiation, invasion, and metastasis of tumor. The phenotypic characteristics of hybrids are based on the phenotypes of parental cells, and the fusion of tumor cells with diverse types of microenvironmental fusogenic cells is concomitant with phenotypic heterogeneity. This review highlights the types of fusogenic cells in tumor microenvironment that can fuse with tumor cells and their specific significance and summarizes the various microenvironmental factors affecting tumor cell fusion. This review may be used as a reference to develop strategies for future research on tumor cell fusion and the exploration of cell fusion-based antitumor therapies.

摘要

细胞融合是一种高度受调控的生物学过程,发生在生理和病理条件下。细胞和细胞外环境对于诱导细胞-细胞融合至关重要。异常的细胞融合发生在肿瘤进展过程中。肿瘤微环境是由肿瘤细胞与其周围细胞相互作用形成的复杂动态系统。细胞-细胞融合介导了肿瘤细胞与其周围细胞之间的直接相互作用,并与肿瘤的起始和进展相关。各种微环境因素影响肿瘤微环境中的细胞融合,并产生获得双亲细胞基因组的杂种细胞,表现出新的特性,如肿瘤干细胞样特性、抗辐射、抗药性、免疫逃逸和增强的迁移和侵袭能力,这些特性与肿瘤的起始、侵袭和转移密切相关。杂种细胞的表型特征基于亲代细胞的表型,并且肿瘤细胞与多种类型的微环境融合细胞的融合伴随着表型异质性。本综述强调了肿瘤微环境中能够与肿瘤细胞融合的融合细胞类型及其特定意义,并总结了影响肿瘤细胞融合的各种微环境因素。本综述可作为未来肿瘤细胞融合研究和基于细胞融合的抗肿瘤治疗探索的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48e/6657644/bc7f63ffb6f6/BMRI2019-5013592.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48e/6657644/f66a1e12c8e9/BMRI2019-5013592.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48e/6657644/bc7f63ffb6f6/BMRI2019-5013592.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48e/6657644/f66a1e12c8e9/BMRI2019-5013592.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48e/6657644/bc7f63ffb6f6/BMRI2019-5013592.002.jpg

相似文献

1
Tumor Microenvironment and Cell Fusion.肿瘤微环境与细胞融合。
Biomed Res Int. 2019 Jul 11;2019:5013592. doi: 10.1155/2019/5013592. eCollection 2019.
2
Eph Receptors: Actors in Tumor Microenvironment.Eph受体:肿瘤微环境中的作用因子
Crit Rev Oncog. 2017;22(5-6):499-505. doi: 10.1615/CritRevOncog.2017020557.
3
Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.遗传和微环境因素在癌症上皮-间充质转化中的作用及其治疗意义。
Exp Cell Res. 2018 Sep 15;370(2):190-197. doi: 10.1016/j.yexcr.2018.07.046. Epub 2018 Jul 31.
4
Overcoming resistance of cancer stem cells.克服癌症干细胞的耐药性。
Lancet Oncol. 2012 May;13(5):e187-8. doi: 10.1016/S1470-2045(12)70196-1.
5
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.基于癌症干细胞的治疗方法的新兴功能标志物:了解用于靶向转移的信号网络。
Semin Cancer Biol. 2018 Dec;53:90-109. doi: 10.1016/j.semcancer.2018.06.006. Epub 2018 Jun 30.
6
[The cellular mechanisms and regulation of metastasis formation].[转移形成的细胞机制与调控]
Mol Biol (Mosk). 2014 Mar-Apr;48(2):195-213.
7
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.基质的环境和细胞力学特性调节细胞迁移,并有助于癌细胞的侵袭表型。
Rep Prog Phys. 2019 Jun;82(6):064602. doi: 10.1088/1361-6633/ab1628. Epub 2019 Apr 4.
8
Genomic alterations in tumor stroma.肿瘤基质中的基因组改变。
Cancer Res. 2009 Sep 1;69(17):6759-64. doi: 10.1158/0008-5472.CAN-09-0985. Epub 2009 Aug 25.
9
Addressing intra-tumoral heterogeneity and therapy resistance.解决肿瘤内异质性和治疗抗性问题。
Oncotarget. 2016 Nov 1;7(44):72322-72342. doi: 10.18632/oncotarget.11875.
10
The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment.细胞外囊泡的作用:癌症微环境的表观遗传学视角
Biomed Res Int. 2015;2015:649161. doi: 10.1155/2015/649161. Epub 2015 Oct 25.

引用本文的文献

1
Tumor microenvironment response to neoadjuvant therapy in breast cancer: insights from single-cell and spatial omics.肿瘤微环境对乳腺癌新辅助治疗的反应:来自单细胞和空间组学的见解
Med Oncol. 2025 Sep 13;42(11):472. doi: 10.1007/s12032-025-03028-1.
2
Bone Marrow Myeloid-Lymphatic Progenitors Expand Tumor Lymphatic Vasculature Through Cell Fusion.骨髓髓系-淋巴系祖细胞通过细胞融合扩展肿瘤淋巴管系统。
Cancers (Basel). 2025 May 28;17(11):1804. doi: 10.3390/cancers17111804.
3
CD300a: An Innate Immune Checkpoint Shaping Tumor Immunity and Therapeutic Opportunity.

本文引用的文献

1
Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma.肿瘤微泡激活成纤维细胞中的糖代谢重编程促进口腔鳞状细胞癌的进展。
FASEB J. 2019 Apr;33(4):5690-5703. doi: 10.1096/fj.201802226R. Epub 2019 Jan 30.
2
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.局部癌症复发:新疗法的现实、挑战和机遇。
CA Cancer J Clin. 2018 Nov;68(6):488-505. doi: 10.3322/caac.21498. Epub 2018 Oct 17.
3
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.
CD300a:一个塑造肿瘤免疫和治疗机会的先天性免疫检查点
Cancers (Basel). 2025 May 27;17(11):1786. doi: 10.3390/cancers17111786.
4
The potential role of Ral-interacting protein 76 and vascular endothelial growth factor on angiogenesis in the tumor and ovarian corpus luteum microenvironment.Ral相互作用蛋白76和血管内皮生长因子在肿瘤及卵巢黄体微环境中血管生成的潜在作用
Transl Cancer Res. 2024 Oct 31;13(10):5702-5710. doi: 10.21037/tcr-24-770. Epub 2024 Oct 17.
5
Hypothesis: hematogenous metastatic cancer cells of solid tumors may disguise themselves as memory macrophages for metastasis.假设:实体瘤的血行转移癌细胞可能会伪装成记忆性巨噬细胞以实现转移。
Front Oncol. 2024 Jul 5;14:1412296. doi: 10.3389/fonc.2024.1412296. eCollection 2024.
6
Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p-ACLY axis.口腔鳞状细胞癌癌相关成纤维细胞中脂质生物合成的增强有助于肿瘤进展:IL8/AKT/p-ACLY 轴的作用。
Cancer Sci. 2024 May;115(5):1433-1445. doi: 10.1111/cas.16111. Epub 2024 Mar 17.
7
The Association between NADPH Oxidase 2 (NOX2) and Drug Resistance in Cancer.NADPH 氧化酶 2(NOX2)与癌症耐药性的关联。
Curr Cancer Drug Targets. 2024;24(12):1195-1212. doi: 10.2174/0115680096277328240110062433.
8
Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out.ZEB1 基因敲除后乳腺上皮×乳腺癌杂交细胞表型的改变。
Int J Mol Sci. 2023 Dec 9;24(24):17310. doi: 10.3390/ijms242417310.
9
The Hallmarks of Circulating Hybrid Cells.循环杂交细胞的特征。
Results Probl Cell Differ. 2024;71:467-485. doi: 10.1007/978-3-031-37936-9_21.
10
A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.一种多功能递药系统,用于重塑循环恶性细胞的行为以防止细胞融合。
Adv Sci (Weinh). 2023 Oct;10(29):e2303309. doi: 10.1002/advs.202303309. Epub 2023 Aug 17.
细胞融合增强了肿瘤异质性,并揭示了与肿瘤分期和生存相关的循环杂交细胞。
Sci Adv. 2018 Sep 12;4(9):eaat7828. doi: 10.1126/sciadv.aat7828. eCollection 2018 Sep.
4
Impact of cell fusion in myeloma marrow microenvironment on tumor progression.骨髓瘤骨髓微环境中的细胞融合对肿瘤进展的影响。
Oncotarget. 2018 Jul 24;9(57):30997-31006. doi: 10.18632/oncotarget.25742.
5
Crosstalk between cancer cells and endothelial cells: implications for tumor progression and intervention.肿瘤细胞与内皮细胞的串扰:对肿瘤进展和干预的影响。
Arch Pharm Res. 2018 Jul;41(7):711-724. doi: 10.1007/s12272-018-1051-1. Epub 2018 Jun 30.
6
Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery.肿瘤细胞 CD163 的表达与保乳手术后接受放疗的乳腺癌患者的术后放疗和预后不良相关。
J Cancer Res Clin Oncol. 2018 Jul;144(7):1253-1263. doi: 10.1007/s00432-018-2646-0. Epub 2018 May 3.
7
Matrix metalloproteinase-9 (MMP9) is involved in the TNF-α-induced fusion of human M13SV1-Cre breast epithelial cells and human MDA-MB-435-pFDR1 cancer cells.基质金属蛋白酶 9(MMP9)参与 TNF-α 诱导的人 M13SV1-Cre 乳腺上皮细胞与人 MDA-MB-435-pFDR1 癌细胞融合。
Cell Commun Signal. 2018 Apr 10;16(1):14. doi: 10.1186/s12964-018-0226-1.
8
Hypoxia Enhances Fusion of Oral Squamous Carcinoma Cells and Epithelial Cells Partly via the Epithelial-Mesenchymal Transition of Epithelial Cells.缺氧通过上皮细胞的上皮-间充质转化部分增强口腔鳞状癌细胞与上皮细胞的融合。
Biomed Res Int. 2018 Feb 8;2018:5015203. doi: 10.1155/2018/5015203. eCollection 2018.
9
In Vitro Fusion of Normal and Neoplastic Breast Epithelial Cells with Human Mesenchymal Stroma/Stem Cells Partially Involves Tumor Necrosis Factor Receptor Signaling.正常和肿瘤乳腺上皮细胞与人间质/干细胞的体外融合部分涉及肿瘤坏死因子受体信号传导。
Stem Cells. 2018 Jul;36(7):977-989. doi: 10.1002/stem.2819. Epub 2018 Mar 28.
10
Cell-cell fusion as a mechanism of DNA exchange in cancer.细胞间融合作为癌症中DNA交换的一种机制。
Oncotarget. 2017 Dec 27;9(5):6156-6173. doi: 10.18632/oncotarget.23715. eCollection 2018 Jan 19.